Oxana Iliach, PhD, Sr. Director Global Regulatory Strategy & CMC, Biosimilars Center of Excellence, IQVIA
Dr. Iliach, Ph.D. is a Senior Director Global Regulatory Strategy and CMC at the Biosimilars Center of Excellence, IQVIA. She has more than 15 years’ experience in healthcare industry, including the last 10 years in regulatory affairs. Her expertise lies in the development of regulatory strategy for biosimilars and biologics with the focus on overall quality and CMC compliance. She has provided a global regulatory strategy and was involved in development for number of products including biosimilars of Avastin®, Herceptin®, Humira®, MabThera®/Rituxan®, Soliris®. She has a PhD in Pharmaceutical Science from St. Petersburg Chemical and Pharmaceutical Academy, Russia. Oxana is also a professor at Seneca College of Applied Arts and Technology, Toronto, Canada and a member of CAPRA (Canadian Association of Professionals in Regulatory Affairs), RAPS and DIA.